19484125|t|Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription.
19484125|a|The NF-E2-related factor-2 (Nrf2)/antioxidant response element (ARE) signaling pathway regulates phase 2 detoxification genes, including a variety of antioxidative enzymes. We tested neuroprotective effects of the synthetic triterpenoid CDDO-MA, a potent activator of the Nrf2/ARE signaling. CDDO-MA treatment of neuroblastoma SH-SY5Y cells resulted in Nrf2 upregulation and translocation from cytosol to nucleus and subsequent activation of ARE pathway genes. CDDO-MA blocked t-butylhydroperoxide-induced production of reactive oxygen species (ROS) by activation of ARE genes only in wild type, but not Nrf2 knockout mouse embryonic fibroblasts. Oral administration of CDDO-MA resulted in significant protection against MPTP-induced nigrostriatal dopaminergic neurodegeneration, pathological alpha-synuclein accumulation and oxidative damage in mice. Additionally, CDDO-MA treatment in rats produced significant rescue against striatal lesions caused by the neurotoxin 3-NP, and associated increases in the oxidative damage markers malondialdehyde, F(2)-Isoprostanes, 8-hydroxy-2-deoxyguanosine, 3-nitrotyrosine, and impaired glutathione homeostasis. Our results indicate that the CDDO-MA renders its neuroprotective effects through its potent activation of the Nrf2/ARE pathway, and suggest that triterpenoids may be beneficial for the treatment of neurodegenerative diseases like Parkinson's disease and Huntington's disease.
19484125	31	43	triterpenoid	Chemical	MESH:D014315
19484125	45	62	CDDO methyl amide	Chemical	MESH:C530803
19484125	84	88	Nrf2	Gene	4780
19484125	117	139	NF-E2-related factor-2	Gene	4780
19484125	141	145	Nrf2	Gene	4780
19484125	337	349	triterpenoid	Chemical	MESH:D014315
19484125	350	357	CDDO-MA	Chemical	-
19484125	385	389	Nrf2	Gene	18024
19484125	405	412	CDDO-MA	Chemical	-
19484125	426	439	neuroblastoma	Disease	MESH:D009447
19484125	440	447	SH-SY5Y	CellLine	CVCL:0019
19484125	466	470	Nrf2	Gene	4780
19484125	574	581	CDDO-MA	Chemical	-
19484125	590	610	t-butylhydroperoxide	Chemical	MESH:D020122
19484125	633	656	reactive oxygen species	Chemical	MESH:D017382
19484125	658	661	ROS	Chemical	MESH:D017382
19484125	717	721	Nrf2	Gene	18024
19484125	731	736	mouse	Species	10090
19484125	783	790	CDDO-MA	Chemical	-
19484125	834	838	MPTP	Chemical	MESH:D015632
19484125	861	891	dopaminergic neurodegeneration	Disease	MESH:D009422
19484125	906	921	alpha-synuclein	Gene	20617
19484125	959	963	mice	Species	10090
19484125	979	986	CDDO-MA	Chemical	-
19484125	1000	1004	rats	Species	10116
19484125	1041	1057	striatal lesions	Disease	MESH:C537500
19484125	1083	1087	3-NP	Chemical	-
19484125	1146	1161	malondialdehyde	Chemical	MESH:D008315
19484125	1163	1180	F(2)-Isoprostanes	Chemical	MESH:D028441
19484125	1182	1208	8-hydroxy-2-deoxyguanosine	Chemical	MESH:D000080242
19484125	1210	1225	3-nitrotyrosine	Chemical	MESH:C002744
19484125	1240	1251	glutathione	Disease	MESH:C536835
19484125	1295	1302	CDDO-MA	Chemical	-
19484125	1376	1380	Nrf2	Gene	4780
19484125	1411	1424	triterpenoids	Chemical	MESH:D014315
19484125	1464	1490	neurodegenerative diseases	Disease	MESH:D019636
19484125	1496	1515	Parkinson's disease	Disease	MESH:D010300
19484125	1520	1540	Huntington's disease	Disease	MESH:D006816
19484125	Negative_Correlation	MESH:D014315	MESH:D010300
19484125	Association	MESH:D014315	4780
19484125	Positive_Correlation	MESH:D015632	20617
19484125	Positive_Correlation	MESH:D017382	MESH:D020122
19484125	Positive_Correlation	MESH:C530803	4780
19484125	Negative_Correlation	MESH:D014315	MESH:D019636
19484125	Positive_Correlation	MESH:D014315	18024
19484125	Positive_Correlation	MESH:D015632	MESH:D009422
19484125	Negative_Correlation	MESH:D014315	MESH:D006816

